Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Allergan
Company Monitoring Page for Allergan
latest headlines for company on cafepharma
Valeant raises proposal for Allergan by $10.00 per share to $58.30 per share
The Fly on the Wall
Wed, 05/28/14 - 09:26 am
Tags:
Valeant Pharmaceuticals
,
M&A
,
Allergan
Allergan investors want up to $200 per share from Valeant
Fierce Pharma
Tue, 05/27/14 - 09:05 pm
Tags:
Valeant Pharmaceuticals
,
Allergan
,
M&A
Allergan criticises performance of Valeant's recent acquisitions
First Word Pharma
Tue, 05/27/14 - 10:08 am
Tags:
Allergan
,
Valeant Pharmaceuticals
,
M&A
Valeant’s Pursuit of Allergan: Go Big or Go Home
Motley Fool
Wed, 05/21/14 - 10:18 am
Tags:
Allergan
,
Valeant Pharmaceuticals
,
M&A
Ackman says Allergan CEO has conflict of interest on takeover offer
Reuters
Mon, 05/19/14 - 03:34 pm
Tags:
Bill Ackman
,
Valeant Pharmaceuticals
,
Allergan
,
M&A
Valeant to consider breakup after mega deals -investors
Reuters
Fri, 05/16/14 - 06:32 pm
Tags:
Valeant Pharmaceuticals
,
restructuring
,
Allergan
,
M&A
Valeant May Improve Allergan Bid on Investor Feedback
Bloomberg
Tue, 05/13/14 - 09:54 am
Tags:
Valeant Pharmaceuticals
,
Allergan
,
M&A
Allergan CEO says 'rumor mill' inconsistent with company history of discreteness
The Fly on the Wall
Mon, 05/12/14 - 09:48 am
Tags:
Allergan
,
Pharma CEOs
,
M&A
,
JNJ
,
GSK
,
Novartis
,
Valeant Pharmaceuticals
Allergan board unanimously rejects cash-stock takeover offer from Valeant Pharma
Yahoo/AP
Mon, 05/12/14 - 09:08 am
Tags:
Allergan
,
Valeant Pharmaceuticals
,
M&A
Allergan Said to Be Rebuffed by Sanofi, J&J as It Seeks Bids
Bloomberg
Sat, 05/10/14 - 11:31 am
Tags:
Allergan
,
JNJ
,
Sanofi
,
M&A
Allergan Reports Strong Q1 While Weighing Valeant Bid
Investors.com
Wed, 05/7/14 - 06:37 pm
Tags:
Allergan
,
earnings
,
Valeant Pharmaceuticals
Up, up, up: After Allergan offer, would-be buyer Ackman reaps $1.2B in gains
Fierce Pharma
Tue, 05/6/14 - 10:49 am
Tags:
Allergan
,
Valeant Pharmaceuticals
,
Bill Ackman
Shire declines to comment on any specifics of 'M&A frenzy'
Reuters
Thu, 05/1/14 - 08:43 am
Tags:
M&A
,
Shire
,
Allergan
Drug Merger Boom Sends Hedging Costs to Eight-Year High
Bloomberg
Wed, 04/30/14 - 08:39 am
Tags:
M&A
,
Gilead Sciences
,
Forest Labs
,
Pfizer
,
Allergan
,
Eli Lilly
Shire Gains on Report Allergan Is Preparing Takeover Bid
Bloomberg
Tue, 04/29/14 - 09:57 am
Tags:
Shire
,
Allergan
,
M&A
,
Valeant Pharmaceuticals
Allergan Said to Explore Sale to Sanofi, J&J
Bloomberg
Tue, 04/29/14 - 09:44 am
Tags:
Allergan
,
Sanofi
,
JNJ
,
M&A
,
Valeant Pharmaceuticals
Irreconcilable differences? Allergan investors wary of suitor Valeant's cost-slashing style
Fierce Pharma
Mon, 04/28/14 - 05:56 pm
Tags:
Allergan
,
Valeant Pharmaceuticals
Allergan likely to receive higher bid from Valeant, says Sterne Agee
Yahoo/Fly on the Wall
Mon, 04/28/14 - 12:33 pm
Tags:
Allergan
,
Valeant Pharmaceuticals
,
M&A
Biotech M&A is MIA
TheStreet.com
Mon, 04/28/14 - 10:18 am
Tags:
M&A
,
biotech
,
Pfizer
,
Alnylam
,
Biogen Idec
,
Celgene
,
GSK
,
Novartis
,
AstraZeneca
,
Allergan
,
Valeant Pharmaceuticals
Allergan made a pass at Shire before Valeant came calling
Fierce Biotech
Fri, 04/25/14 - 09:53 am
Tags:
Valeant Pharmaceuticals
,
M&A
,
Allergan
,
Shire
Pages
« first
‹ previous
…
42
43
44
45
46
47
48
49
50
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.